ATAI Life Sciences NV (ATAI)
1.85
-0.06
(-3.14%)
USD |
NASDAQ |
Apr 19, 16:00
1.80
-0.05
(-2.70%)
After-Hours: 20:00
ATAI Life Sciences Debt to Equity Ratio: 0.0736 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0736 |
| September 30, 2023 | 0.0577 |
| June 30, 2023 | 0.0719 |
| March 31, 2023 | 0.0642 |
| December 31, 2022 | 0.058 |
| September 30, 2022 | 0.0518 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.002 |
| March 31, 2022 | 0.0021 |
| December 31, 2021 | 0.002 |
| September 30, 2021 | 0.0018 |
| June 30, 2021 | 0.0026 |
| March 31, 2021 | 0.0266 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0018
Minimum
Sep 2021
0.0736
Maximum
Dec 2023
0.0345
Average
0.0392
Median
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.2102 |
| InflaRx NV | 0.00 |
| MorphoSys AG | 12.71 |
| BioNTech SE | 0.0108 |
| Immatics NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 293.48M |
| Total Liabilities (Quarterly) | 49.16M |
| Shareholders Equity (Quarterly) | 242.96M |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | -0.25% |